Passage Bio Inc (NASDAQ: PASG) kicked off on Friday, up 7.03% from the previous trading day, before settling in for the closing price of $0.52. Over the past 52 weeks, PASG has traded in a range of $0.45-$1.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 47.04%. With a float of $51.93 million, this company’s outstanding shares have now reached $61.77 million.
Let’s look at the performance matrix of the company that is accounted for 58 employees. In terms of profitability, gross margin is 59.18%, operating margin of -1261.43%, and the pretax margin is -1163.73%.
Passage Bio Inc (PASG) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Passage Bio Inc is 15.93%, while institutional ownership is 44.91%. The most recent insider transaction that took place on Feb 11 ’25, was worth 1,686. In this transaction CFO of this company sold 3,183 shares at a rate of $0.53, taking the stock ownership to the 41,283 shares. Before that another transaction happened on Jan 10 ’25, when Company’s 10% Owner sold 126,209 for $0.66, making the entire transaction worth $83,298. This insider now owns 7,131,636 shares in total.
Passage Bio Inc (PASG) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 47.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.39% during the next five years compared to -46.23% drop over the previous five years of trading.
Passage Bio Inc (NASDAQ: PASG) Trading Performance Indicators
Take a look at Passage Bio Inc’s (PASG) current performance indicators. Last quarter, stock had a quick ratio of 5.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.66 in one year’s time.
Technical Analysis of Passage Bio Inc (PASG)
Passage Bio Inc (NASDAQ: PASG) saw its 5-day average volume 0.13 million, a negative change from its year-to-date volume of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 28.29%. Additionally, its Average True Range was 0.06.
During the past 100 days, Passage Bio Inc’s (PASG) raw stochastic average was set at 12.40%, which indicates a significant decrease from 46.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.25% in the past 14 days, which was lower than the 144.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6537, while its 200-day Moving Average is $0.8061. Nevertheless, the first resistance level for the watch stands at $0.5978 in the near term. At $0.6357, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6714. If the price goes on to break the first support level at $0.5242, it is likely to go to the next support level at $0.4885. The third support level lies at $0.4506 if the price breaches the second support level.
Passage Bio Inc (NASDAQ: PASG) Key Stats
The company with the Market Capitalisation of 34.59 million has total of 61,767K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -102,060 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -19,340 K.
